BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11367931)

  • 1. Aseptic efficacy of prefilled syringes in a polluted environment.
    Ninomiya N; Koido Y; Yamamoto Y
    Prehosp Disaster Med; 2001; 16(1):14-7. PubMed ID: 11367931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Prefilled Buffered Lidocaine Syringes With and Without Epinephrine.
    Pate DA; Shimizu I; Akin R; Snodgrass K; Emrick A
    Dermatol Surg; 2016 Mar; 42(3):361-5. PubMed ID: 26859654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump.
    Mitrano FP; Baptista RJ; Newton DW; Augustine SC
    Am J Hosp Pharm; 1986 Jan; 43(1):78-80. PubMed ID: 3953587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiologic contamination and time efficiency of use of automatic MDCT injectors with prefilled syringes: Results of a clinical investigation.
    Buerke B; Puesken M; Mellmann A; Seifarth H; Heindel W; Wessling J
    AJR Am J Roentgenol; 2010 Feb; 194(2):299-303. PubMed ID: 20093587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic MDCT injectors: hygiene and efficiency of disposable, prefilled, and multidosing roller pump systems in clinical routine.
    Buerke B; Puesken M; Mellmann A; Schuelke C; Knauer A; Heindel W; Wessling J
    AJR Am J Roentgenol; 2011 Aug; 197(2):W226-32. PubMed ID: 21785046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug contamination from opening glass ampules.
    Zacher AN; Zornow MH; Evans G
    Anesthesiology; 1991 Nov; 75(5):893-5. PubMed ID: 1952213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial contamination of re-usable and disposable syringes and needles.
    Danchaivijitr S; Leelaporn A; Kongsamran S
    J Med Assoc Thai; 1989 Jul; 72 Suppl 2():26-8. PubMed ID: 2769128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-destructive vacuum decay method for pre-filled syringe closure integrity testing compared with dye ingress testing and high-voltage leak detection.
    Simonetti A; Amari F
    PDA J Pharm Sci Technol; 2015; 69(1):108-22. PubMed ID: 25691719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, double-blind comparison of the injection pain and anesthetic onset of 2% lidocaine with 1:100,000 epinephrine buffered with 5% and 10% sodium bicarbonate in maxillary infiltrations.
    Hobeich P; Simon S; Schneiderman E; He J
    J Endod; 2013 May; 39(5):597-9. PubMed ID: 23611375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cross-infection related to the multiple use of disposable syringes.
    Trépanier CA; Lessard MR; Brochu JG; Denault PH
    Can J Anaesth; 1990 Mar; 37(2):156-9. PubMed ID: 2311144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Container Closure Integrity Testing of Prefilled Syringes.
    Peláez SS; Mahler HC; Matter A; Koulov A; Singh SK; Germershaus O; Mathaes R
    J Pharm Sci; 2018 Aug; 107(8):2091-2097. PubMed ID: 29626532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lidocaine alert: beware of hooded syringes.
    Cohen MR
    Nursing; 1990 Dec; 20(12):15. PubMed ID: 2267088
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected high risk of contamination with staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units.
    van Grafhorst JP; Foudraine NA; Nooteboom F; Crombach WH; Oldenhof NJ; van Doorne H
    Crit Care Med; 2002 Apr; 30(4):833-6. PubMed ID: 11940754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of presterile disposable syringes and needles marketed in Pune.
    Sali NM; Pratinidhi AK; Bhardwaj RS; Khare AS; Yemul VL
    Indian J Med Sci; 2001 Jun; 55(6):313-8. PubMed ID: 11885508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three modified lidocaine solutions for use in eyelid anesthesia.
    Yuen VH; Dolman PJ
    Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):143-7. PubMed ID: 10189646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringes.
    Pascuet E; Donnelly RF; Garceau D; Vaillancourt R
    Can J Hosp Pharm; 2009 Sep; 62(5):375-80. PubMed ID: 22478919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic impact of strategies using ephedrine prefilled syringes].
    Crégut-Corbaton J; Malbranche C; Guignard MH; Fagnoni P
    Ann Fr Anesth Reanim; 2013 Nov; 32(11):760-5. PubMed ID: 24135730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of conditions for the production scale sterilization of prefilled syringes.
    Nishimoto N; Maekawa T
    PDA J Pharm Sci Technol; 2003; 57(5):378-86. PubMed ID: 14677630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I; Federici M; Kaiser V; Thiesen J
    J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.